A Study of AK0529 in Chinese Infants Hospitalized With RSV
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, multicenter, phase III study to be
conducted in infants hospitalized with RSV infection in China. The main objectives of this
study are to investigate the efficacy and safety of AK0529 in Chinese infants.